Drug · DIN 02543850
TEMBEXA
Authorized, not yet reported as sold
Authorized for sale in Canada; the company has not yet told Health Canada that it is on the market.
Status Approved since December 11, 2023.
- Drug Identification Number (DIN)
- 02543850
- Company (DIN owner)
- Emergent Biodefense Operations Lansing LlcLansing, Michigan, United States
- Schedule
- Prescription recommended
- Dosage form
- Suspension
- Route
- Oral
- Therapeutic class (ATC)
- Brincidofovir J05AB17
- Class
- Human
- Record last updated
- July 29, 2025
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| BRINCIDOFOVIR | 10 MG | ML |
Notices of Compliance
Health Canada approvals that name this DIN.
- December 11, 2023: NOC 32329New Drug Submission (NDS)
Other DINs named TEMBEXA
- DIN 02543842 · Restricted Access